Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ford

Showing results (1391-1400 of 1,411) with videos related to

Pageof 142
Sort By:
Science Translational Medicine|July 19, 2019
A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challengeScott G Hansen, Emily E Marshall, Daniel Malouli, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
A quantitative proteomics dataset for assessment and prediction of low dose X-ray radiation exposure in miceAlex Zelter, Michael Riffle, Gennifer E Merrihew, et al.
Science (New York, N.Y.)|May 25, 2013
Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigmsScott G Hansen, Jonah B Sacha, Colette M Hughes, et al.
ACS Medicinal Chemistry Letters|January 17, 2024
Fluorinated Isoindolinone-Based Glucosylceramide Synthase Inhibitors with Low Human Dose ProjectionsH Marie Loughran, Kathy M Schirripa, Anthony J Roecker, et al.
BMJ Open|July 8, 2021
Repetitive transcranial magnetic stimulation (rTMS) in autism spectrum disorder: protocol for a multicentre randomised controlled clinical trialPeter G Enticott, Karen Barlow, Adam J Guastella, et al.
The Journal of Organic Chemistry|July 9, 2016
Effect of Buffer Conditions and Organic Cosolvents on the Rate of Strain-Promoted Azide-Alkyne CycloadditionDerek L Davis, Erin K Price, Sabrina O Aderibigbe, et al.
Nature|June 22, 2017
Addendum: Immune clearance of highly pathogenic SIV infectionScott G Hansen, Michael Piatak, Abigail B Ventura, et al.
Scientific Reports|February 27, 2025
The MEK inhibitor trametinib is effective in inhibiting the growth of canine oral squamous cell carcinomaWilliam P Katt, Cheryl E Balkman, Scott D Butler, et al.
The Lancet. Neurology|December 2, 2015
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trialRhonda R Voskuhl, HeJing Wang, T C Jackson Wu, et al.
Science Immunology|March 26, 2021
Cytomegaloviral determinants of CD8<sup>+</sup> T cell programming and RhCMV/SIV vaccine efficacyDaniel Malouli, Scott G Hansen, Meaghan H Hancock, et al.
Pageof 142

Showing results (1391-1400 of 1,411) with videos related to

Sort By:
Pageof 142
Science Translational Medicine|July 19, 2019
A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challengeScott G Hansen, Emily E Marshall, Daniel Malouli, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
A quantitative proteomics dataset for assessment and prediction of low dose X-ray radiation exposure in miceAlex Zelter, Michael Riffle, Gennifer E Merrihew, et al.
Science (New York, N.Y.)|May 25, 2013
Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigmsScott G Hansen, Jonah B Sacha, Colette M Hughes, et al.
ACS Medicinal Chemistry Letters|January 17, 2024
Fluorinated Isoindolinone-Based Glucosylceramide Synthase Inhibitors with Low Human Dose ProjectionsH Marie Loughran, Kathy M Schirripa, Anthony J Roecker, et al.
BMJ Open|July 8, 2021
Repetitive transcranial magnetic stimulation (rTMS) in autism spectrum disorder: protocol for a multicentre randomised controlled clinical trialPeter G Enticott, Karen Barlow, Adam J Guastella, et al.
The Journal of Organic Chemistry|July 9, 2016
Effect of Buffer Conditions and Organic Cosolvents on the Rate of Strain-Promoted Azide-Alkyne CycloadditionDerek L Davis, Erin K Price, Sabrina O Aderibigbe, et al.
Nature|June 22, 2017
Addendum: Immune clearance of highly pathogenic SIV infectionScott G Hansen, Michael Piatak, Abigail B Ventura, et al.
Scientific Reports|February 27, 2025
The MEK inhibitor trametinib is effective in inhibiting the growth of canine oral squamous cell carcinomaWilliam P Katt, Cheryl E Balkman, Scott D Butler, et al.
The Lancet. Neurology|December 2, 2015
Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trialRhonda R Voskuhl, HeJing Wang, T C Jackson Wu, et al.
Science Immunology|March 26, 2021
Cytomegaloviral determinants of CD8<sup>+</sup> T cell programming and RhCMV/SIV vaccine efficacyDaniel Malouli, Scott G Hansen, Meaghan H Hancock, et al.
Pageof 142